Hyderabad Telangana, India

Sritharan Seetharaman


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sritharan Seetharaman in Pharmaceutical Chemistry

Introduction

Sritharan Seetharaman is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. His work focuses on improving the efficacy and stability of pharmaceutical compounds.

Latest Patents

One of his key patents is titled "Amorphous mirabegron and processes for crystal forms of mirabegron." This invention relates to the amorphous form of mirabegron, an innovative solid dispersion of the drug, and the processes for its preparation. Additionally, it includes methods for preparing the α form and β form crystal of mirabegron, along with the pharmaceutical compositions derived from these forms. Sritharan holds 1 patent in this area.

Career Highlights

Sritharan Seetharaman is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in drug development. His role involves extensive research and development aimed at enhancing drug formulations and therapeutic outcomes.

Collaborations

Throughout his career, Sritharan has collaborated with several talented professionals, including Vishweshwar Peddy and Rajesham Boge. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical sciences.

Conclusion

In summary, Sritharan Seetharaman is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug formulation. His contributions, particularly in the area of mirabegron, highlight the importance of innovation in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…